Global /United States /Healthcare /Medical Devices /NPCE
chevron_leftBack
NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE
NASDAQ: NPCE Delayed
16.56USD -2%
As of 13 June 2026, NeuroPace, Inc. has a market cap of $562.05M USD, ranking #14361 globally and #2561 in the United States. It ranks #1277 in the Healthcare sector, and #256 in the Medical Devices industry.
Global Rank
14361
Country Rank
2561
Sector Rank
1277
Industry Rank
256
Key Stats
Market Cap
$562.05MUSD
Enterprise Value
$558.61MUSD
Revenue (TTM)
$99.99MUSD
EBITDA (TTM)
-$16.1MUSD
Net Income (TTM)
-$21.47MUSD
EBITDA Margin
-16%
Profit Margin
-21%
PS Ratio
5.5
PB Ratio
29.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Joel Becker open_in_new
Employees
209
Founded
1997
IPO
22 Apr 2021
Website
neuropace.com open_in_new
1d 1w 1m 3m 6m 1y
-2% -2.5% 24% 6.1% 56% 42%

News

Loading...

NPCE Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
NPCE
NeuroPace Inc
ISIN: US6412881053
Shares Out.:
34.094M1 Shares Float: 26.111M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
16.56 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
31K%
25.8
$160.73B
28K%
56.7
$159.07B
28K%
25.6
DHR
$126.55B
22K%
34.7
SYK
$120.69B
21K%
38.3
$84.93B
15K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
18K%
22.2
$97.46B
84.32B EUR
17K%
36.7
7741
$61.41B
9.83T JPY
11K%
40.0
$45.47B
39.34B EUR
8K%
18.7
ALC
$36.38B
28.99B CHF
6K%
37.9
$30.06B
203.66B CNY
5K%
26.0
chevron_leftBack